Urotronic Inc.

This study is checking the safety and effectiveness of the Optilume BPH Catheter System, a device already on the market, for treating urinary problems caused by an enlarged prostate. It will follow 92 men for 12 months to see if their symptoms improve and to monitor for any serio…

This study is testing a new device called the Optilume Drug-Coated Balloon to treat ureteral strictures, which are narrowings in the tube that carries urine from the kidney to the bladder. The main goal is to see if using this balloon, which is coated with a drug called paclitaxe…

This study is creating a registry to track the real-world results of a treatment called the Optilume BPH Catheter System. It will follow 500 men who have already received this treatment for their symptomatic enlarged prostate (BPH). The main goal is to see how much their urinary …

This study is checking if a treatment for a narrowed urethra (a tube in the penis) affects a man's sperm. It will follow 34 men for up to a year after they get the Optilume treatment. The main goal is to see if sperm concentration changes at 3 and 6 months after the procedure.